METHYLPREDNISOLONE, Placebo of CRESEMBA, CRESEMBA 200 mg powder for concentrate for solution for infusion, Placebo of methylprednisolone
APHP180584
Phase 3 small_molecule active
Quick answer
METHYLPREDNISOLONE, Placebo of CRESEMBA, CRESEMBA 200 mg powder for concentrate for solution for infusion, Placebo of methylprednisolone for patients with acute respiratory failure from undetermined etiology is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- patients with acute respiratory failure from undetermined etiology
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active